Literature DB >> 29168098

Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating 18F-FDG-PET Imaging with the ALBI Grade.

Tomoaki Yoh1, Satoru Seo2, Satoshi Ogiso1, Takayuki Kawai1, Yukihiro Okuda1, Takamichi Ishii1, Kojiro Taura1, Tatsuya Higashi3, Yuji Nakamoto4, Etsuro Hatano5, Toshimi Kaido1, Shinji Uemoto1.   

Abstract

BACKGROUND: Existing prognostic systems were not developed using only objective variables available preoperatively, and therefore do not provide ideal prognostication for patients undergoing hepatectomy for hepatocellular carcinoma (HCC). We aimed to develop a preoperative prognostic model using objective variables involving two parameters: 18F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) and the albumin-bilirubin (ALBI) grade.
METHODS: This study included 207 consecutive patients with solitary HCC who underwent 18F-FDG-PET prior to hepatectomy. The tumor to non-tumor maximum standardized uptake value ratio (TNR) was used as an 18F-FDG PET imaging parameter.
RESULTS: The 5-year overall survival (OS) and disease-free survival (DFS) rates were 58.6% and 28.8%, respectively. Multivariate analysis of OS identified TNR ≥ 2 (hazard ratio [HR] 1.743, 95% confidence interval [CI] 1.114-2.648, p = 0.016) and ALBI grade 2 (HR 1.966, 95% CI 1.349-2.884, p < 0.001) as the only significant prognostic factors; tumor diameter and tumor markers were not significant. Patients were divided into low- (TNR < 2 and ALBI grade 1), intermediate- (TNR < 2 and ALBI grade 2, or TNR ≥ 2 and ALBI grade 1), and high-risk (TNR ≥ 2 and ALBI grade 2) groups, which differed significantly in terms of survival (5-year OS: 75.7, 49.6, and 27.3%, respectively, p < 0.001; 5-year DFS: 37.0, 24.9, and 13.6%, respectively, p < 0.001). Compared with other staging systems, our model had the best discriminatory ability (corrected Akaike information criteria 1054.8, p < 0.001) and homogeneity (likelihood ratio Chi square value 27.6, p < 0.001).
CONCLUSION: A preoperative prognostic model incorporating 18F-FDG-PET imaging with the ALBI grade may be useful for estimating the prognosis of selected patients with solitary HCC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29168098     DOI: 10.1245/s10434-017-6262-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

Review 1.  Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.

Authors:  Hyungjin Rhee; Haeryoung Kim; Young Nyun Park
Journal:  Liver Cancer       Date:  2020-10-23       Impact factor: 11.740

2.  Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy.

Authors:  Yutaro Hori; Satoru Seo; Tomoaki Yoh; Kentaro Ueno; Koshiro Morino; Rei Toda; Takahiro Nishio; Yukinori Koyama; Ken Fukumitsu; Takamichi Ishii; Koichiro Hata; Toshihiko Masui; Kojiro Taura; Etsuro Hatano
Journal:  Ann Surg Oncol       Date:  2022-06-12       Impact factor: 4.339

Review 3.  18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches.

Authors:  Arno Kornberg; Helmut Friess
Journal:  Therap Adv Gastroenterol       Date:  2019-03-19       Impact factor: 4.802

4.  A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.

Authors:  Yang-Xun Pan; Jian-Cong Chen; Ai-Ping Fang; Xiao-Hui Wang; Jin-Bin Chen; Jun-Cheng Wang; Wei He; Yi-Zhen Fu; Li Xu; Min-Shan Chen; Yao-Jun Zhang; Qi-Jiong Li; Zhong-Guo Zhou
Journal:  Cancer Commun (Lond)       Date:  2019-10-11

5.  Prognostic value of pretreatment albumin to bilirubin ratio in patients with hepatocellular cancer: A meta-analysis.

Authors:  Yi-Xin Xu; Yi-Bo Wang; Yu-Lin Tan; Cheng Xi; Xue-Zhong Xu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.

Authors:  Ayman Bannaga; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

7.  Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation.

Authors:  Shinji Itoh; Tomoharu Yoshizumi; Yoshiyuki Kitamura; Kyohei Yugawa; Norifumi Iseda; Tomonari Shimagaki; Yoshihiro Nagao; Takeo Toshima; Noboru Harada; Kenichi Kohashi; Shingo Baba; Kousei Ishigami; Yoshinao Oda; Masaki Mori
Journal:  Hepatol Commun       Date:  2021-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.